Laboratory data were assessed immediately prior to rosuvastatin EOD therapy and at the first follow-up. Results: Myalgias (76.5%) and increased transaminase levels (19.5%) were the most common ...

The recent ASTEROID substudy reported that rosuvastatin therapy resulted in ... and raising HDL-C (Figure 5), consistent with the findings of atheroma volume with intravascular ultrasound.